Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Research Report 2023

Publication ID:

PB504241485

Publication Date:

May 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Continuous Glucose Monitoring (CGM) System for Diabetes Management market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Continuous Glucose Monitoring (CGM) System for Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Continuous Glucose Monitoring (CGM) System for Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management include Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment and San Meditech, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM) System for Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) System for Diabetes Management.
The Continuous Glucose Monitoring (CGM) System for Diabetes Management market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) System for Diabetes Management manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type
Wearable
Implantable
Segment by Application
Hospitals & Clinics
Homecare Settings
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) System for Diabetes Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Overview
1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM) System for Diabetes Management
1.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value Comparison by Type (2023-2029)
1.2.2 Wearable
1.2.3 Implantable
1.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Value by Application: (2023-2029)
1.3.2 Hospitals & Clinics
1.3.3 Homecare Settings
1.4 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2018-2029
1.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2018-2029
1.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Manufacturers (2018-2023)
2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturers (2018-2023)
2.4 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management, Product Type & Application
2.7 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Competitive Situation and Trends
2.7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) System for Diabetes Management Players Market Share by Revenue
2.7.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Retrospective Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2018-2029
3.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2018-2023
3.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region: 2024-2029
3.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2018-2029
3.3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2018-2023
3.3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region: 2024-2029
3.4 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2018-2029)
3.4.3 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2018-2029)
3.5.3 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2018-2029)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2018-2029)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2018-2029)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2018-2029)
4.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2018-2023)
4.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2024-2029)
4.1.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2018-2029)
4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2018-2029)
4.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2018-2023)
4.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2024-2029)
4.2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2018-2029)
4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Type (2018-2029)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2018-2029)
5.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2018-2023)
5.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2024-2029)
5.1.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2018-2029)
5.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2018-2029)
5.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2018-2023)
5.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2024-2029)
5.2.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2018-2029)
5.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Diabetes Care Inc.
6.1.1 Abbott Diabetes Care Inc. Corporation Information
6.1.2 Abbott Diabetes Care Inc. Description and Business Overview
6.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.1.5 Abbott Diabetes Care Inc. Recent Developments/Updates
6.2 Dexcom
6.2.1 Dexcom Corporation Information
6.2.2 Dexcom Description and Business Overview
6.2.3 Dexcom Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dexcom Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.2.5 Dexcom Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Senseonics Holdings
6.4.1 Senseonics Holdings Corporation Information
6.4.2 Senseonics Holdings Description and Business Overview
6.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Senseonics Holdings Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.4.5 Senseonics Holdings Recent Developments/Updates
6.5 GlySens Incorporated
6.5.1 GlySens Incorporated Corporation Information
6.5.2 GlySens Incorporated Description and Business Overview
6.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlySens Incorporated Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.5.5 GlySens Incorporated Recent Developments/Updates
6.6 Meiqi Medical Equipment
6.6.1 Meiqi Medical Equipment Corporation Information
6.6.2 Meiqi Medical Equipment Description and Business Overview
6.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.6.5 Meiqi Medical Equipment Recent Developments/Updates
6.7 San Meditech
6.6.1 San Meditech Corporation Information
6.6.2 San Meditech Description and Business Overview
6.6.3 San Meditech Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue and Gross Margin (2018-2023)
6.4.4 San Meditech Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolio
6.7.5 San Meditech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Mode & Process
7.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors
7.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Customers
8 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Trends
8.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers
8.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Challenges
8.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂